Form 4 Tracker
Natera, Inc.
NTRA

118 insider filings · Latest: Aug 10, 2026

Common Stock Transactions
Txn DateAcceptedInsiderTypeSharesAvg PriceValueShares OwnedFiling
Aug 3, 2026Aug 3 8:20 PMMICHAEL BROPHY
Proposed Sale
313$267.76$83.8K

View →

Aug 3, 2026Aug 3 8:18 PMSTEVEN L CHAPMAN
Proposed Sale
1,894$265.40$502.7K

View →

Aug 3, 2026Aug 3 8:09 PMSOLOMON MOSHKEVICH
Proposed Sale
3,000$265.25$795.8K

View →

Jul 28, 2026Jul 30 1:35 AMJonathan SheenaDirector, Other
Sale
191$254.07$48.5K245,723(D)

View →

Jul 27, 2026Jul 30 1:35 AMJonathan SheenaDirector, Other
Sale
288$260.49$75.0K245,914(D)

View →

Jul 27, 2026Jul 30 1:35 AMMatthew RabinowitzDirector, EXECUTIVE CHAIRMAN
Sale
1,718$260.49$447.5K2,276,125(D)

View →

Jul 28, 2026Jul 30 1:35 AMDaniel RabinowitzSEC. AND CHIEF LEGAL OFFICER
Sale
1,003$254.07$254.8K170,407(D)

View →

Jul 27, 2026Jul 30 1:35 AMDaniel RabinowitzSEC. AND CHIEF LEGAL OFFICER
Sale
884$260.49$230.3K171,410(D)

View →

Jul 28, 2026Jul 30 1:35 AMSolomon MoshkevichPRESIDENT, CLINICALDIAGNOSTICS
Sale
1,204$254.07$305.9K132,429(D)

View →

Jul 27, 2026Jul 30 1:35 AMSolomon MoshkevichPRESIDENT, CLINICALDIAGNOSTICS
Sale
1,010$260.49$263.1K133,633(D)

View →

Jul 28, 2026Jul 30 1:35 AMJohn FeskoPRESIDENT, CHIEF BUS. OFFICER
Sale
931$254.07$236.5K184,069(D)

View →

Jul 27, 2026Jul 30 1:35 AMJohn FeskoPRESIDENT, CHIEF BUS. OFFICER
Sale
782$260.49$203.7K185,000(D)

View →

Jul 28, 2026Jul 30 1:35 AMSteven Leonard ChapmanDirector, CEO AND PRESIDENT
Sale
3,580$254.07$909.6K102,973(D)

View →

Jul 27, 2026Jul 30 1:35 AMSteven Leonard ChapmanDirector, CEO AND PRESIDENT
Sale
2,190$260.49$570.5K106,553(D)

View →

Jul 29, 2026Jul 30 1:35 AMMichael Burkes BrophyCHIEF FINANCIAL OFFICER
Sale
1,863$249.38$464.6K52,432(D)

View →

Jul 28, 2026Jul 30 1:35 AMMichael Burkes BrophyCHIEF FINANCIAL OFFICER
Sale
2,419$253.96$614.3K54,295(D)

View →

Jul 27, 2026Jul 30 1:35 AMMichael Burkes BrophyCHIEF FINANCIAL OFFICER
Sale
782$260.49$203.7K56,714(D)

View →

Jul 29, 2026Jul 29 8:21 PMMICHAEL BROPHY
Proposed Sale
1,863$252.22$469.9K

View →

Jul 28, 2026Jul 28 8:40 PMMICHAEL BROPHY
Proposed Sale
1,178$258.03$304.0K

View →

Jul 28, 2026Jul 28 8:08 PMJONATHAN SHEENA
Proposed Sale
188$258.03$48.5K

View →

Stock Options & Derivatives
Txn DateAcceptedInsiderTypeSharesExercise PriceShares OwnedFiling
Jun 5, 2026Jun 10 1:05 AMGail Boxer MarcusDirector
Option Exercise
11,000$22.8311,000(D)

View →

Apr 6, 2026Apr 9 1:05 AMMatthew RabinowitzDirector, EXECUTIVE CHAIRMAN
Option Exercise
58,292$9.590(D)

View →

Mar 31, 2026Apr 2 1:05 AMMatthew RabinowitzDirector, EXECUTIVE CHAIRMAN
Option Exercise
41,708$9.5958,292(D)

View →

Mar 16, 2026Mar 17 1:05 AMMatthew RabinowitzDirector, EXECUTIVE CHAIRMAN
Option Exercise
50,000$9.59100,000(D)

View →

Mar 13, 2026Mar 17 1:05 AMMatthew RabinowitzDirector, EXECUTIVE CHAIRMAN
Option Exercise
75,000$9.59150,000(D)

View →

Mar 12, 2026Mar 17 1:05 AMMatthew RabinowitzDirector, EXECUTIVE CHAIRMAN
Option Exercise
75,000$9.59225,000(D)

View →

Mar 6, 2026Mar 11 1:05 AMDaniel RabinowitzSEC. AND CHIEF LEGAL OFFICER
Option Exercise
5,598$19.680(D)

View →

Mar 2, 2026Mar 4 2:05 AMSolomon MoshkevichPRESIDENT, CLINICALDIAGNOSTICS
Option Exercise
5,125$9.590(D)

View →

Jan 20, 2026Jan 23 2:35 AMSteven Leonard ChapmanDirector, CEO AND PRESIDENT
Option Exercise
3,3860(D)

View →

Jan 20, 2026Jan 23 2:35 AMMichael Burkes BrophyCHIEF FINANCIAL OFFICER
Option Exercise
1,5220(D)

View →

Jan 20, 2026Jan 23 2:05 AMJonathan SheenaDirector, Other
Option Exercise
1910(D)

View →

Jan 20, 2026Jan 23 2:05 AMDaniel RabinowitzSEC. AND CHIEF LEGAL OFFICER
Option Exercise
8560(D)

View →